Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR... Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology. Show more
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that management will participate in the following...
On track to present additional clinical data from the RUBY trial and the EdiTHAL trial by year-end In vivo preclinical proof-of-concept for an undisclosed indication on-track by year-end Strong...
CAMBRIDGE, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will host a conference call and webcast...
All patients treated in the RUBY trial are free of vaso-occlusive events post-renizgamglogene autogedtemcel (reni-cel) infusion Patients had early normalization of total hemoglobin with a mean...
All patients treated in the EdiTHAL trial maintained hemoglobin levels above the transfusion threshold and are transfusion-free post-renizgamglogene autogedtemcel (reni-cel) infusion Reni-cel was...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.25 | -6.39386189258 | 3.91 | 4.12 | 3.6 | 3332692 | 3.81403947 | CS |
4 | -0.22 | -5.67010309278 | 3.88 | 4.12 | 3.4 | 2000635 | 3.73446303 | CS |
12 | -0.95 | -20.6073752711 | 4.61 | 6.05 | 3.4 | 1733578 | 4.3841237 | CS |
26 | -3.78 | -50.8064516129 | 7.44 | 7.595 | 3.4 | 1900261 | 5.11021629 | CS |
52 | -4.09 | -52.7741935484 | 7.75 | 11.69 | 3.4 | 1906087 | 6.93914841 | CS |
156 | -57.65 | -94.0303376284 | 61.31 | 61.54 | 3.4 | 1797754 | 12.19827487 | CS |
260 | -20.73 | -84.9938499385 | 24.39 | 99.95 | 3.4 | 1635870 | 23.41035613 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.